105 related articles for article (PubMed ID: 25743813)
1. Expression and prognostic implications of FOXO3a and Ki67 in lung adenocarcinomas.
Liu HB; Gao XX; Zhang Q; Liu J; Cui Y; Zhu Y; Liu YF
Asian Pac J Cancer Prev; 2015; 16(4):1443-8. PubMed ID: 25743813
[TBL] [Abstract][Full Text] [Related]
2. Low expression of Foxo3a is associated with poor prognosis in ovarian cancer patients.
Fei M; Zhao Y; Wang Y; Lu M; Cheng C; Huang X; Zhang D; Lu J; He S; Shen A
Cancer Invest; 2009 Jan; 27(1):52-9. PubMed ID: 19160093
[TBL] [Abstract][Full Text] [Related]
3. Expression of PH Domain Leucine-rich Repeat Protein Phosphatase, Forkhead Homeobox Type O 3a and RAD51, and their Relationships with Clinicopathologic Features and Prognosis in Ovarian Serous Adenocarcinoma.
Zhang J; Wang JC; Li YH; Wang RX; Fan XM
Chin Med J (Engl); 2017 Feb; 130(3):280-287. PubMed ID: 28139510
[TBL] [Abstract][Full Text] [Related]
4. Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy.
Li X; Liu J; Qian L; Ke H; Yao C; Tian W; Liu Y; Zhang J
Mol Cell Biochem; 2018 Aug; 445(1-2):123-134. PubMed ID: 29327288
[TBL] [Abstract][Full Text] [Related]
5. ANCCA protein expression is a novel independent poor prognostic marker in surgically resected lung adenocarcinoma.
Zhang Y; Sun Y; Li Y; Fang Z; Wang R; Pan Y; Hu H; Luo X; Ye T; Li H; Wang L; Chen H; Ji H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S577-82. PubMed ID: 23775406
[TBL] [Abstract][Full Text] [Related]
6. Ly6/uPAR-related protein C4.4A as a marker of solid growth pattern and poor prognosis in lung adenocarcinoma.
Jacobsen B; Muley T; Meister M; Dienemann H; Christensen IJ; Santoni-Rugiu E; Lærum OD; Ploug M
J Thorac Oncol; 2013 Feb; 8(2):152-60. PubMed ID: 23287851
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of the FOXO3a gene is associated with poor prognosis in primary gastric adenocarcinoma patients.
Yang XB; Zhao JJ; Huang CY; Wang QJ; Pan K; Wang DD; Pan QZ; Jiang SS; Lv L; Gao X; Chen HW; Yao JY; Zhi M; Xia JC
PLoS One; 2013; 8(10):e78158. PubMed ID: 24194912
[TBL] [Abstract][Full Text] [Related]
8. The expression and significance of pThr32-FOXO3a in human ovarian cancer.
Lu M; Xiang J; Xu F; Wang Y; Yin Y; Chen D
Med Oncol; 2012 Jun; 29(2):1258-64. PubMed ID: 21452041
[TBL] [Abstract][Full Text] [Related]
9. High expression levels of MAGE-A9 are correlated with unfavorable survival in lung adenocarcinoma.
Zhai X; Xu L; Zhang S; Zhu H; Mao G; Huang J
Oncotarget; 2016 Jan; 7(4):4871-81. PubMed ID: 26717042
[TBL] [Abstract][Full Text] [Related]
10. Fibulin-1 functions as a prognostic factor in lung adenocarcinoma.
Cui Y; Liu J; Yin HB; Liu YF; Liu JH
Jpn J Clin Oncol; 2015 Sep; 45(9):854-9. PubMed ID: 26185140
[TBL] [Abstract][Full Text] [Related]
11. Impact of GLUT1 and Ki-67 expression on early‑stage lung adenocarcinoma diagnosed according to a new international multidisciplinary classification.
Maki Y; Soh J; Ichimura K; Shien K; Furukawa M; Muraoka T; Tanaka N; Ueno T; Yamamoto H; Asano H; Tsukuda K; Toyooka S; Miyoshi S
Oncol Rep; 2013 Jan; 29(1):133-40. PubMed ID: 23076555
[TBL] [Abstract][Full Text] [Related]
12. Expression of keratinocyte growth factor/fibroblast growth factor-7 and its receptor in human lung cancer: correlation with tumour proliferative activity and patient prognosis.
Yamayoshi T; Nagayasu T; Matsumoto K; Abo T; Hishikawa Y; Koji T
J Pathol; 2004 Sep; 204(1):110-8. PubMed ID: 15307144
[TBL] [Abstract][Full Text] [Related]
13. TGF-β1 protein expression in non-small cell lung cancers is correlated with prognosis.
Huang AL; Liu SG; Qi WJ; Zhao YF; Li YM; Lei B; Sheng WJ; Shen H
Asian Pac J Cancer Prev; 2014; 15(19):8143-7. PubMed ID: 25338997
[TBL] [Abstract][Full Text] [Related]
14. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D
BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
[TBL] [Abstract][Full Text] [Related]
16. Foxo3a expression is a prognostic marker in breast cancer.
Jiang Y; Zou L; Lu WQ; Zhang Y; Shen AG
PLoS One; 2013; 8(8):e70746. PubMed ID: 23967095
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome and expression of mutant P53, P16, and Smad4 in lung adenocarcinoma: a prospective study.
Bian C; Li Z; Xu Y; Wang J; Xu L; Shen H
World J Surg Oncol; 2015 Mar; 13():128. PubMed ID: 25890228
[TBL] [Abstract][Full Text] [Related]
18. RBX1 expression is an unfavorable prognostic factor in patients with non-small cell lung cancer.
Xing R; Chen KB; Xuan Y; Feng C; Xue M; Zeng YC
Surg Oncol; 2016 Sep; 25(3):147-51. PubMed ID: 27566015
[TBL] [Abstract][Full Text] [Related]
19. FOXO3a expression is associated with lymph node metastasis and poor disease-free survival in triple-negative breast cancer.
Rehman A; Kim Y; Kim H; Sim J; Ahn H; Chung MS; Shin SJ; Jang K
J Clin Pathol; 2018 Sep; 71(9):806-813. PubMed ID: 29588373
[TBL] [Abstract][Full Text] [Related]
20. MCM2 and Ki-67 expression in human lung adenocarcinoma: prognostic implications.
Hashimoto K; Araki K; Osaki M; Nakamura H; Tomita K; Shimizu E; Ito H
Pathobiology; 2004; 71(4):193-200. PubMed ID: 15263808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
